نتائج البحث - "Guzel Mukhametshina"

1

Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial

المصدر: Journal of Clinical Oncology. 41:1830-1840

مصطلحات موضوعية: Cancer Research, Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2e4209c2a30ea8588f1e79771f3c93f7Test
https://doi.org/10.1200/jco.22.02186Test

2

Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer

المصدر: Breast Cancer Research and Treatment
Breast cancer research and treatment, vol 188, iss 2

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Receptor, ErbB-2, ErbB-2, 0302 clinical medicine, Trastuzumab, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Overall survival, skin and connective tissue diseases, Humanized, Cancer, education.field_of_study, Biosimilar, Metastatic breast cancer, Clinical Trial, Treatment Outcome, 6.1 Pharmaceuticals, 030220 oncology & carcinogenesis, Female, Receptor, medicine.drug, medicine.medical_specialty, Randomization, Clinical Trials and Supportive Activities, Clinical Sciences, Oncology and Carcinogenesis, Population, Breast Neoplasms, Antibodies, Monoclonal, Humanized, Antibodies, 03 medical and health sciences, Breast cancer, Clinical Research, Internal medicine, Breast Cancer, medicine, Humans, Oncology & Carcinogenesis, education, Until Disease Progression, neoplasms, Taxane, business.industry, Evaluation of treatments and therapeutic interventions, medicine.disease, Survival Analysis, 030104 developmental biology, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d96d7db24623d3a61483158ddd9eb8f3Test
https://doi.org/10.1007/s10549-021-06197-5Test

3

Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis

المؤلفون: Karen A. Gelmon, Peter A. Fasching, Fergus J. Couch, Judith Balmaña, Suzette Delaloge, Intidhar Labidi-Galy, James Bennett, Susan McCutcheon, Graham Walker, Joyce O'Shaughnessy, Constanta Timcheva, Antoaneta Tomova, Andrea Eisen, Karen Gelmon, Julie Lemieux, Fernando Bazan, Hugues Bourgeois, Camille Chakiba, Mohamad Chehimi, Florence Dalenc, Thibault De La Motte Rouge, Jean-Sébastien Frenel, Anthony Gonçalves, Anne Claire Hardy-Bessard, Regine Lamy, Christelle Levy, Alain Lortholary, Audrey Mailliez, Jacques Medioni, Anne Patsouris, Dominique Spaeth, Luis Teixeira, Isabelle Tennevet, Cristian Villanueva, Benoit You, Johannes Ettl, Bernd Gerber, Oliver Hoffmann, Tjoung-Won Park-Simon, Mattea Reinisch, Joke Tio, Pauline Wimberger, Katalin Boer, Alberto Ballestrero, Giampaolo Bianchini, Laura Biganzoli, Roberto Bordonaro, Francesco Cognetti, Michelino De Laurentiis, Sabino De Placido, Valentina Guarneri, Filippo Montemurro, Giuseppe Naso, Armando Santoro, Claudio Zamagni, Seung-Jin Kim, Seigo Nakamura, Yee Soo Chae, Eun Kyung Cho, Kim Jee Hyun, Seock-Ah Im, Keun Seok Lee, Yeon Hee Park, Joo Hyuk Sohn, Tomasz Byrski, Tomasz Huzarski, Bozena Kukielka-Budny, Zbigniew Nowecki, Renata Szoszkiewicz, Rafal Tarnawski, Viktoria Dvornichenko, Fedor Moiseenko, Guzel Mukhametshina, Elena Poddubskaya, Ekaterina Popova, Anna Tarasova, Anna Vats, Bárbara Adamo, Raquel Andrés Conejero, Antonio Antón Torres, Judith Balmaña Gelpi, Nieves Díaz Fernández, Alejandro Falcón González, Juan Garcia, Isabel Lorenzo-Lorenzo, Fernando Moreno Antón, Marta Santisteban, Agostina Stradella, Chiun-Sheng Huang, Sercan Aksoy, Cagatay Arslan, Mehmet Artac, Adnan Aydiner, Ozgur Ozyilkan, Emel Sezer, Anne Armstrong, Sophie Barrett, Annabel Borley, Zoe Kemp, Caroline Michie, Mukesh Mukesh, Timothy Perren, Angela Swampillai, Tammy Young

المصدر: European journal of cancer (Oxford, England : 1990). 152

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Receptor, ErbB-2, BRCA2 gene, Effectiveness, Piperazines, chemistry.chemical_compound, BRCA1 gene, 0302 clinical medicine, Breast cancer, Olaparib, ErbB-2, Germline mutation, Treatment outcome, Adjuvant, BRCA1 Protein, Middle Aged, Metastatic breast cancer, Progression-Free Survival, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Metastatic, Female, Receptor, Adult, medicine.medical_specialty, Anthracycline, Breast Neoplasms, Poly(ADP-ribose) Polymerase Inhibitors, 03 medical and health sciences, Young Adult, Progression-free survival, Aged, BRCA2 Protein, Germ-Line Mutation, Humans, Phthalazines, Internal medicine, medicine, Chemotherapy, Adverse effect, Taxane, business.industry, medicine.disease, Interim analysis, 030104 developmental biology, chemistry, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf39309b7bb719fd0c3675e31c646e0cTest
https://pubmed.ncbi.nlm.nih.gov/34087573Test

4

The results of the first retrospective data analysis of eribulin application in patients with metastatic breast cancer in actual clinical practice in Russia

المصدر: Современная онкология, Vol 18, Iss 3, Pp 27-32 (2016)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fa75504345f75181bf935130bbd9f72Test
https://modernonco.orscience.ru/1815-1434/article/viewFile/27073/pdfTest

5

Efficacy and safety of eribulin in combination with trastuzumab in HER2-positive metastatic breast cancer patients: Real life experience

المصدر: European Journal of Cancer. 138:S59

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.disease, Metastatic breast cancer, chemistry.chemical_compound, chemistry, Trastuzumab, Internal medicine, medicine, business, Eribulin, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::242c7a41dbceb73647084b375877da34Test
https://doi.org/10.1016/s0959-8049Test(20)30684-5

6

المؤلفون: Cornelius F. Waller, Aleksei Manikhas, Eduardo J. Pennella, Igor Bondarenko, Guzel Mukhametshina, Maria Luisa Abesanis Tiambeng, Charuwan Akewanlop, Ihor Vynnychenko, Virote Sriuranpong, Sirshendu Ray, Miguel Hernandez-Bronchud, Jay Herson, Joseph D. Parra, Gia Nemsadze, Unmesh Gopalakrishnan, Subramanian Loganathan, Rafael Muniz, Abhijit Barve, Hope S. Rugo

المصدر: Journal of Clinical Oncology. 37:1021-1021

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Combination therapy, business.industry, Biosimilar, 03 medical and health sciences, 0302 clinical medicine, Trastuzumab, 030220 oncology & carcinogenesis, Internal medicine, Overall survival, Medicine, skin and connective tissue diseases, business, neoplasms, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::63039a9ce89216fb07c4644a33551536Test
https://doi.org/10.1200/jco.2019.37.15_suppl.1021Test

7

Aflibercept (Afl) for patients (pts) with metastatic colorectal cancer (mCRC): Clinical predictors of nonhematologic (nonhem) toxicity

المصدر: Journal of Clinical Oncology. 37:e15007-e15007

مصطلحات موضوعية: Oncology, Cardiovascular toxicity, Cancer Research, medicine.medical_specialty, business.industry, Drug discontinuation, Colorectal cancer, medicine.disease, Internal medicine, Toxicity, medicine, business, Aflibercept, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::6679c8662d0e014b4fc65b96621512d2Test
https://doi.org/10.1200/jco.2019.37.15_suppl.e15007Test

8

المؤلفون: Virote Sriuranpong, Aleksei Manikhas, Sirshendu Ray, Abhijit Barve, Hope S. Rugo, Ihor Vynnychenko, Charuwan Akewanlop, Maria Luisa T. Abesamis-Tiambeng, Jay Herson, Miguel H. Bronchud, Cornelius F. Waller, Subramanian Loganathan, Guzel Mukhametshina, Eduardo J. Pennella, Igor Bondarenko

المصدر: Journal of Clinical Oncology. 36:110-110

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::6ac09927a779a12ddd550e13716b3ec4Test
https://doi.org/10.1200/jco.2018.36.15_suppl.110Test

9

Long-term responders with metastatic breast cancer (MBC) receiving eribulin: Real life experience

المؤلفون: Dmitry Ponomarenko, Tatiana Semiglazova, Elena Karabina, Alfia Khasanova, Ludmila Manzyuk, Elena Kovalenko, Guzel Mukhametshina, Larisa Zhilyaeva, Larisa Bolotina, Vera Gorbunova, Irina V. Evstigneeva

المصدر: Journal of Clinical Oncology. 36:e13065-e13065

مصطلحات موضوعية: Eribulin Mesylate, Oncology, Cancer Research, medicine.medical_specialty, Vinca, Microtubule dynamics, biology, business.industry, biology.organism_classification, medicine.disease, Metastatic breast cancer, chemistry.chemical_compound, chemistry, Internal medicine, medicine, business, Eribulin

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8d0dbd378b7cb5e87f94e2e53e84d874Test
https://doi.org/10.1200/jco.2018.36.15_suppl.e13065Test

10

Heritage: A phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus Herceptin

المصدر: Journal of Clinical Oncology. 34:LBA503-LBA503

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a0982ab432ec41ff58a8ce58303797dTest
https://doi.org/10.1200/jco.2016.34.18_suppl.lba503Test

تنقيح النتائج